BioAge LabsBioAge Labs
BioAge Labs

BioAge Labs

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

2019Active99

About

BioAge Labs is a clinical-stage biotechnology company leveraging AI to discover and develop novel therapies for age-related diseases. They aim to identify biological pathways that drive aging and target them with small molecule drugs to improve healthspan and lifespan. Their approach focuses on identifying targets that can be modulated by existing, approved drugs, accelerating the path to clinical application.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$690/mo
EmailGoogle Workspace
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does BioAge Labs do?

BioAge Labs is a clinical-stage biotechnology company leveraging AI to discover and develop novel therapies for age-related diseases. They aim to identify biological pathways that drive aging and target them with small molecule drugs to improve healthspan and lifespan. Their approach focuses on identifying targets that can be modulated by existing, approved drugs, accelerating the path to clinical application.

Where is BioAge Labs headquartered?

BioAge Labs is headquartered in New Haven, United States.

When was BioAge Labs founded?

BioAge Labs was founded in 2019.

What industry does BioAge Labs operate in?

BioAge Labs operates in Biotech, HealthTech, Longevity, Drug Discovery, Clinical Trials, AI-Driven Drug Discovery.

How many employees does BioAge Labs have?

BioAge Labs has approximately 99 people on record.